CMS Proposes New Transparency Measures to Strengthen Oversight of Hospice Providers

Why It Matters

The measures tighten federal oversight, protecting beneficiaries from fraud while giving families clearer data to choose quality hospice care, and they signal higher compliance costs for providers.

Key Takeaways

• CMS proposes unannounced site visits to audit hospice compliance.
• New Medicare.gov icon will flag hospices failing quality reporting.
• Over 200 hospice enrollments revoked in high‑risk states last year.
• FY2027 hospice payment rate increase of 2.4% adds $785 million.
• Scoring system will assess non‑hospice spending and readmission metrics.

Pulse Analysis

CMS’s latest proposal reflects a data‑driven shift in federal hospice oversight, aiming to curb the rising tide of fraud and inappropriate utilization that has strained Medicare’s budget. By deploying unannounced inspections and a transparent scoring model, the agency can pinpoint outliers—such as excessive non‑hospice spending or unusually long stays—while rewarding providers that meet rigorous quality benchmarks. This approach builds on earlier efforts in Arizona, California, Nevada, Texas, Georgia and Ohio, where more than 200 hospice enrollments were revoked for non‑compliance, signaling a tougher enforcement posture.

The scoring system will be publicly accessible on Medicare.gov’s Care Compare platform, where a new icon will instantly identify hospices that failed to meet the Hospice Quality Reporting Program (HQRP) standards. Approximately one‑fifth of hospices missed reporting requirements in 2025, a figure CMS expects to shrink through heightened visibility and accountability. Metrics such as average minutes of routine home‑care, live‑discharge rates, and repeat admissions within seven days will feed into a composite score, giving families a clearer, evidence‑based tool for provider selection.

For hospice operators, the rule introduces both risk and opportunity. While the threat of revocation and the need to invest in compliance infrastructure may increase operating costs, the proposed 2.4% payment uplift—equating to an estimated $785 million boost for FY 2027—offers financial relief. Providers that excel in the new scoring framework could differentiate themselves in a competitive market, attracting referrals and potentially securing higher reimbursement rates. Overall, the initiative is poised to reshape hospice economics, enhance patient safety, and reinforce Medicare’s commitment to transparent, high‑quality end‑of‑life care.